Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 96 of the 101 references it cites were found in a registry or an index; 33 of the 53 sources its claims cite were checked for support.

Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome

Open access

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder that impacts women of reproductive age. In addition to reproductive and psychological complications, women with PCOS are also at a higher risk of developing metabolic diseases such as obesity, type 2 diabetes and cardiovascular disease. While weight reduction can help manage these complications in overweight or obese women, many weight loss interventions have been ineffective due to weight stigma and its psychological impact on women with PCOS. Therefore, exploring alternative dietary strategies which do not focus on weight loss per se is of importance. In this regard, omega-3 polyunsaturated fatty acids of marine origin (n-3 PUFAs), which are known for their hypotriglyceridemic, cardioprotective and anti-inflammatory effects, have emerged as a potential therapy for prevention and reversal of metabolic complications in PCOS. Several clinical trials showed that n-3 PUFAs can improve components of metabolic syndrome in women with PCOS. In this review, we first summarize the available clinical evidence for different dietary patterns in improving PCOS complications. Next, we summarize the clinical evidence for n-3 PUFAs for alleviating metabolic complications in PCOS. Finally, we explore the mechanisms by which n-3 PUFAs improve the metabolic disorders in PCOS in depth.

Overview

CoChat Summary

TL;DR

This is a narrative review arguing that omega-3 polyunsaturated fatty acids, especially marine EPA and DHA, may help improve metabolic dysfunction in PCOS. The paper concludes that n-3 PUFAs can reduce triglycerides, improve insulin resistance, and lower inflammation, but says mechanistic evidence is still limited.

Key findings

  • In a meta-analysis of 9 randomized controlled studies (591 women with PCOS), n-3 PUFA supplementation decreased HOMA-IR, total cholesterol, and triglycerides; triglycerides fell by a mean of 29.21 mg/dl (95% CI −48.08, −10.34).
  • Another meta-analysis of 11 randomized controlled trials (816 women with PCOS) found beneficial effects of n-3 PUFAs, especially in trials longer than 8 weeks, on HOMA-IR, triglycerides, cholesterol, and adiponectin.
  • A meta-analysis of 10 randomized clinical trials reported that n-3 PUFA supplementation decreased hs-CRP and increased adiponectin in women with PCOS.
  • In a meta-analysis of 10 randomized controlled trials (610 patients), n-3 PUFA decreased total testosterone and increased SHBG; a cited randomized cross-over study found that 2.4 g/day EPA + DHA for 6 weeks significantly reduced bioavailable testosterone.

Methods

  • Narrative review of PCOS diagnosis, pathophysiology, dietary patterns, and the clinical/mechanistic literature on n-3 PUFAs.
  • Synthesizes evidence from clinical trials, meta-analyses, cross-sectional/case-control studies, and animal studies; no original participant sample was recruited by this paper.
  • Main analysis is qualitative synthesis of reported effects and proposed mechanisms, with specific trial and meta-analysis results summarized in the text.

Limitations

  • The paper states that only a few mechanistic studies are available to explain how n-3 PUFAs improve PCOS-related outcomes.
  • The paper states that the mechanisms by which n-3 PUFAs reduce androgen production and increase SHBG in PCOS warrant further research.
  • Evident from the text: this is a narrative review, so it does not present a new pooled meta-analysis or original dataset of its own.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nu16172961

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Pathogenesis of metabolic derangements in PCOS.
Figure 1 Pathogenesis of metabolic derangements in PCOS.CC BY · PubMed Central
Figure 2 Mechanisms by which EPA/DHA improve metabolic derangements in PCOS.
Figure 2 Mechanisms by which EPA/DHA improve metabolic derangements in PCOS.CC BY · PubMed Central

Verification

Claims the paper makes

28 Valid · 1 Not valid · 12 Not checked · 5 Own results and interpretations

18 more claims · 9 with their cited sources checked

Create a free account to see all 46 claims and to verify the 7 references still open.

See all claims — free account
  • It may state two separate claims as one. 22
  • Probably not a substantial claim. 2

Create a free account to see these claims.

Citations

Cites

Show all 101 references

Cited by

See all 18

Metadata

Authors
Albardan, L., Platat, C., & Kalupahana, N. S.
Affiliations
United Arab Emirates University (AE)
Corresponding author
Kalupahana, Nishan Sudheera
Venue
Nutrients
Publisher
MDPI AG
Published
2024-09-03
Volume
16
Issue
17
Pages
2961
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4402198951
Cited by
18
References
101
Citations by year
2026: 6 · 2025: 9 · 2024: 3
FWCI
1.26
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
United Arab Emirates University (G00004624)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
polycystic ovary syndrome, omega-3 fatty acids, metabolic dysfunction, metabolic syndrome, obesity, type 2 diabetes, cardiovascular disease, dietary intervention, weight stigma, anti-inflammatory activity, hypotriglyceridemic effect, cardioprotection
MeSH terms
Female, Humans, Obesity, Polycystic Ovary Syndrome, Fatty Acids, Omega-3, Dietary Supplements, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome. https://app.cochat.ai/papers/10.3390/nu16172961
The paper
Albardan, L., Platat, C., & Kalupahana, N. S. (2024). Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome. Nutrients. https://doi.org/10.3390/nu16172961

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.